Charles Schwab
HGEN

Charles Schwab’s HUMANIGEN, INC. HGEN Stock Holding History

Charles Schwab’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-262,756
Closed -$466K – 3564
2022
Q2 		$466K Sell
262,756
-66,275
-20% -$149K ﹤0.01% 3104
2022
Q1 		$991K Sell
329,031
-13,879
-4% -$37.1K ﹤0.01% 2850
2021
Q4 		$1.28M Buy
342,910
+24,993
+8% +$146K ﹤0.01% 2825
2021
Q3 		$1.89M Sell
317,917
-5,420
-2% -$76.1K ﹤0.01% 2715
2021
Q2 		$5.62M Buy
323,337
+131,426
+68% +$2.4M ﹤0.01% 2291
2021
Q1 		$3.67M Buy
191,911
+5,068
+3% +$92.5K ﹤0.01% 2445
2020
Q4 		$3.27M Buy
+186,843
New +$2.24M ﹤0.01% 2426

Other funds holding HGEN

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Charles Schwab's HGEN Position: Q3 2022 in Review

Charles Schwab sold out of HUMANIGEN, INC. (HGEN) in Q3 2022, closing a stake of 262,756 shares — an estimated $466K sold.

Charles Schwab first reported a position in HGEN in Q4 2020 and held it in 7 quarters. The position peaked at $5.62M in Q2 2021. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

  • Charles Schwab reported no remaining HUMANIGEN, INC. position as of Q3 2022 after selling out during the quarter.
  • Charles Schwab sold 262,756 HUMANIGEN, INC. shares in Q3 2022, an estimated $466K.
  • Charles Schwab first reported a position in HUMANIGEN, INC. in Q4 2020 and held it in 7 quarters.
  • Charles Schwab's HUMANIGEN, INC. position peaked at $5.62M in Q2 2021.
  • 53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on Charles Schwab's 13F filing for Q3 2022, filed 14 Nov 2022.